The University of Warwick Library - WebBridge

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo) : an open-label, 2×2 factorial randomised phase 3 trial
Earl, Helena M..  The Lancet Oncology.  v. Volume 15. no. Number 2.   2014-02-01. p. 201 - 212... issn: 1470-2045 .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.